Our understanding of the role of the vascular endothelium has
evolved over the past two decades, with the recognition that it is a dynamically
regulated organ and that it plays a nodal role in a variety of physiological and
pathological processes. Endothelial cells (ECs) are not only a barrier between
the circulation and peripheral tissues, but also actively regulate vascular
tone, blood flow and platelet function. Dysregulation of ECs contributes to
pathological conditions such as vascular inflammation, atherosclerosis,
hypertension, cardiomyopathy, retinopathy, neuropathy and cancer. The close
anatomical relationship between vascular endothelium and highly vascularized
metabolic organs/tissues suggests that the crosstalk between ECs and these
organs is vital for both vascular and metabolic homeostasis. Numerous reports
support that hyperlipidemia, hyperglycemia and other metabolic stresses result
in endothelial dysfunction and vascular complications. However, how ECs may
regulate metabolic homeostasis remains poorly understood. Emerging data suggest
that the vascular endothelium plays an unexpected role in the regulation of
metabolic homeostasis and that endothelial dysregulation directly contributes to
the development of metabolic disorders. Here, we review recent studies about the
pivotal role of ECs in glucose and lipid homeostasis. In particular, we
introduce the concept that the endothelium adjusts its barrier function to
control the trans-endothelial transport of fatty acids, lipoproteins,
lipoprotein lipases, glucose and insulin. In addition, we summarize reports that
ECs communicate with metabolic cells through EC-secreted factors and we discuss
how endothelial dysregulation contributes directly to the development of
obesity, insulin resistance, dyslipidemia, diabetes, cognitive defects and fatty
liver disease.